Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	106.53	46.03	22.29
Graham Fair Price	-35.68	40173.18	62454.42
PEG	-0.40	-0.61	-0.60
Price/Book	8.10	0.33	0.31
Price/Cash Flow	-2404.89	-380.24	-15.18
Prices/Earnings	166.25	35.78	13.44
Price/Sales	2.69	0.89	0.86
Price/FCF	-2404.89	-380.24	-15.18
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-8.42	0.23	0.25
Operating Margin	-21.96	0.10	0.12
ROA	-58.76	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-59.40
ROIC	0.01	< 0.005	-34.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.01	0.05	-75.30
Dividends QOQ	-0.68	6.01	778.85
EBIT QOQ	1.27	-0.17	-86.53
EPS QOQ	-0.22	-0.59	-165.18
FCF QOQ	-1.63	0.96	-41.41
Revenue QOQ	0.13	0.06	-50.21
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	90.93	87.03	-4.29
Days Sales Outstanding (DSO)	57.25	53.19	-7.08
Inventory Turnover	0.99	1.03	4.48
Debt/Capitalization	0.60	0.60	-0.90
Quick Ratio	0.63	0.61	-3.29
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	173543.74	205371.26	18.34
Cash	46033.32	38574.54	-16.20
Capex	-3563.64	4218.18	18.37
Free Cash Flow	-3537.55	-154.11	95.64
Revenue	62088.05	65978.07	6.27
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.00	0.97	-3.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	18.00	36.75	104.18
Naive Interpretation	Member

06 - Financial Health · Bad

Rating